Evidence map clause
Sources and precedence
This clause and its evidence summary follow the authored EVIDENCE-MAP.md section.
Evidence map clause · EVIDENCE-MAP.md
Map clause: Sources and precedence.
Source heading anchors: spec/README.md#sources-and-precedence
Spec revision / decision reference: v1.2 (pinned fragment locally verified); section-level D references are listed in the source classification. Last reviewed: 2026-10-07.
Type: Normative source precedence and historical record; empirical only where a cited benchmark claim is attached.
Evidence and status: R53, R56, R57, R64, R69, R70, R71, R72, R74, and T98 remain separate by cohort and status. Their coverage and denominator rows are INTERIM unless a cited claim says otherwise; R74 remains WITHDRAWN. Historical source claims in
CL-WA-r53-source-reported-denominator-variants,CL-WA-r56-source-reported-denominator-variants,CL-WA-r57-source-reported-denominator-variants,CL-WA-r64-source-reported-denominator-variants,CL-WA-r69-source-reported-denominator-variants,CL-WA-r70-source-reported-denominator-variants,CL-WA-r71-source-reported-denominator-variants, andCL-WA-r74-source-reported-denominator-variantsare INTERIM or WITHDRAWN as recorded in the ledger. Repeated summary percentages are not additional experiments. Related hypotheses: H86–H90, H111–H116.Unresolved measurement: Reconcile each cited claim to immutable cell IDs, official grades, exact cohort, current harness/Kogen revision, model/effort, accounting definition, and registered analysis rule; preserve corrections and superseded cohorts in the provenance record.